Stocks Health care PAVM

NASDAQ · Health care

PAVmed Inc. (PAVM)

PAVmed Inc. brought in $112K of revenue over the twelve months to June 30, 2026, down 88.8% from a year earlier. It posted a net loss of $12.1M. In fiscal 2025 capital spending exceeded operating cash flow by $5.2M. At June 30, 2026 it held $3.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch PAVM in 60 seconds

Follow PAVM

Free, no password. An email when PAVM files with the SEC.

Key facts about PAVmed Inc.

Net worth

PAVmed Inc. has a market value (market cap) of $12.5M at the latest share price, and shareholders' equity of $35M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Revenue and profit

Over the 12 months to June 30, 2026: revenue $112K, net loss $12.1M.

Cash flow

In fiscal 2025 operations used $5.2M of cash.

Latest report

The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR

Next earnings report

PAVmed Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What PAVmed Inc. does

PAVmed Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PAVM.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where PAVM ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What PAVmed Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 10, 2026
   Material agreement 8-K
2. August 14, 2026
   Quarterly results 8-K
3. August 13, 2026
   Passive stake changed SCHEDULE 13G/A
4. August 13, 2026
   Quarterly report 10-Q · period to June 30, 2026Revenue rose 450% to $33K versus the same quarter last year; diluted EPS -$0.87 versus -$22.08.
5. July 30, 2026
   Employee stock plan registration S-8
6. June 24, 2026
   Executive or director change 8-K
7. May 15, 2026
   Passive stake (5% or more) SCHEDULE 13G
8. May 15, 2026
   Quarterly results 8-K
9. May 14, 2026
   Quarterly report 10-Q · period to March 31, 2026Revenue rose 175% to $22K versus the same quarter last year; diluted EPS -$4.42 versus $10.10.
10. May 14, 2026
    Passive stake (5% or more) SCHEDULE 13G

Recent insider filings (Forms 3, 4 and 144): 10, the latest on April 13, 2026. Insider transactions on SEC

Insider trades

What the people running PAVmed Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PAVM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 20 managers reported a position.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

10 insiders reported holding 950,854 shares in total, about $1.5M at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PAVM

What does PAVmed Inc. do?

PAVmed Inc. is a company in the Health care sector, listed on NASDAQ as PAVM. Its shares trade on NASDAQ under the ticker PAVM.

What is PAVmed Inc.'s net worth?

PAVmed Inc. has a market value (market cap) of $12.5M at the latest share price, and shareholders' equity of $35M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is PAVmed Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $12.1M on revenue of $112K.

How much revenue does PAVmed Inc. make?

Over the twelve months to June 30, 2026 PAVmed Inc. reported revenue of $112K. That is 88.8% less than a year earlier.

When did PAVmed Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 10, 2026.

When is PAVmed Inc.'s next earnings report?

PAVmed Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare PAVM with

Compare PAVM with any company

Follow PAVM

Get an email when PAVmed Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PAVM

Free, no password. An email when PAVM files with the SEC.

Where the numbers come from

Financial figures are the values PAVmed Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.